Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Hongbin Ji, Julien Dilly et al.|Cancer Cell|2024Cited by 115
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor EfficacySuman Mukhopadhyay, Benjamin G. Neel|Cancer Research|2023Cited by 102
Adeno-to-squamous transition drives resistance to KRAS inhibition in <i>LKB1</i> mutant lung cancerXinyuan Tong, Hongbin Ji, Ayushi S. Patel et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1
Exploiting Cancer Cell Signaling and Metabolism: Implications for Therapeutic ApproachSuman Mukhopadhyay|CUNY Academic Works (City University of New York)|2015Cited by 0